Discover
WHWK
Whitehawk Therapeutics, Inc.
4.30
2 x 3.48
2 x 5.55
bid
ask
-
0.28
6.11%
2 @ 04:00 PM
4.30 +0.00 (0.00%)
| Ytd | 77.69% | |
| 1y | 131.18% |
4.28
day range
4.85
1.57
52 week range
5.50
| Open | 4.55 | Prev Close | 4.58 | Low | 4.28 | High | 4.85 | Mkt Cap | 212.65M |
| Vol | 394.36K | Avg Vol | 412.34K | EPS | -2.49 | P/E | N/A | Forward P/E | N/A |
| Beta | N/A | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 4.28 | 200-d Avg | 3.12 | 1yr Est | 0.00 |
| Income Statement | |||
| Operating Expenses | 23.52M | ||
| Research and Development Expense | 17.23M | ||
| Selling, General and Administrative Expense | 6.29M | ||
| Operating Income | -23.52M | ||
| Net Income | -22.19M | ||
| Net Income Common Stock | -22.19M | ||
| Net Income Common Stock (USD) | -22.19M | ||
| Consolidated Income | -22.19M | ||
| Earnings per Basic Share | -0.32 | ||
| Earnings per Basic Share (USD) | -0.32 | ||
| Earnings per Diluted Share | -0.32 | ||
| Earning Before Interest & Taxes (EBIT) | -22.19M | ||
| Earning Before Interest & Taxes (USD) | -22.19M | ||
| Weighted Average Shares | 69.24M | ||
| Weighted Average Shares Diluted | 69.24M | ||
| Balance Sheet | |||
| Cash and Equivalents | 34.79M | ||
| Cash and Equivalents (USD) | 34.79M | ||
| Investments | 88.25M | ||
| Investments Current | 88.25M | ||
| Current Assets | 125.55M | ||
| Property, Plant & Equipment Net | 2.00K | ||
| Total Assets | 127.23M | ||
| Current Liabilities | 11.06M | ||
| Total Liabilities | 11.06M | ||
| Accumulated Retained Earnings (Deficit) | -375.44M | ||
| Accumulated Other Comprehensive Income | -15.00K | ||
| Shareholders Equity | 116.18M | ||
| Shareholders Equity (USD) | 116.18M | ||
| Assets Non-Current | 1.68M | ||
| Trade and Non-Trade Payables | 1.75M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1000 | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -2.78M | ||
| Net Cash Flow from Investing | 19.43M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 19.43M | ||
| Net Cash Flow from Operations | -22.21M | ||
| Share Based Compensation | 2.19M | ||